Bill
HRES 1285
Expressing the sense of the House of Representatives that over 25 years of real-world evidence and hundreds of peer-reviewed studies proving that mifepristone is safe and effective should be respected, and law and policy governing access to lifesaving, time-sensitive medication abortion care in the United States should be equitable, transparent, and based on the best available peer-reviewed evidence-based science.
119th Congress
Introduced by Becca Balint and 49 co-sponsors
Declares mifepristone safe and effective and urges policy to be science-based, equitable, and transparent in access to time-sensitive medication abortion.
Submitted in House